- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Medicare MCOs have edge in managing medications
One less-noticed aspect of the Medicare prescription drug program aims to control spending on medicines by paying special attention to high-use patients, something that may give Medicare managed care plans an advantage. The Medicare Modernization Act (MMA) requires prescription drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs) to establish Medication Therapy Management Programs (MTMPs) for seniors with multiple chronic diseases who spend more than $4,000 a year on medicines. The goal is to ensure appropriate prescribing, boost compliance with drug regimens and reduce adverse events for those patients who take several medications.
WASHINGTON, D.C.-One less-noticed aspect of the Medicare prescription drug program aims to control spending on medicines by paying special attention to high-use patients, something that may give Medicare managed care plans an advantage. The Medicare Modernization Act (MMA) requires prescription drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs) to establish Medication Therapy Management Programs (MTMPs) for seniors with multiple chronic diseases who spend more than $4,000 a year on medicines. The goal is to ensure appropriate prescribing, boost compliance with drug regimens and reduce adverse events for those patients who take several medications.
This policy poses challenges for most PDPs, but may provide a competitive advantage for MA-PDs to deliver quality care. Effective MTMP initiatives are likely to boost drug spending as a way to keep patients out of hospitals and doctors' offices. This represents a cost-effective way to provide better care for MA plans that cover both medical services and prescription drugs. But stand-alone PDPs have little to gain from this trade-off.
UPFRONT INVESTMENT
Many PDPs are expected to turn to retail pharmacists or other specialists to provide counseling to patients on appropriate medication use. Plans also may use nurses and other in-house staff to carry out MTMP services. The program may be a boon to all if it succeeds in improving compliance with prescribed medicines and in reducing side effects, and pharmacists support the requirement as a way to gain reimbursement from drug plans.
CMS has provided little guidance on how drug plans should meet the MTMP requirement but promises to do so. The agency will be looking for ways to measure if these programs have an impact on pharmacy compliance and drug safety problems, as well as health outcomes.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
